Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Currently, there is no known cure for psoriasis ... in patients with chronic moderate-to-severe plaque psoriasis involving the hands and feet. The 12-week study was the first randomized, double ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Severe cases may require treatment with powerful psoriasis medications, including: Trexall (methotrexate) Sandimmune (cyclosporine) Biologic drugs, including Enbrel (etanercept), Remicade ...

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...